vs
Side-by-side financial comparison of CHEMUNG FINANCIAL CORP (CHMG) and RxSight, Inc. (RXST). Click either name above to swap in a different company.
RxSight, Inc. is the larger business by last-quarter revenue ($32.6M vs $23.8M, roughly 1.4× CHEMUNG FINANCIAL CORP). CHEMUNG FINANCIAL CORP runs the higher net margin — 32.5% vs -28.1%, a 60.5% gap on every dollar of revenue. On growth, CHEMUNG FINANCIAL CORP posted the faster year-over-year revenue change (20.3% vs -18.9%). CHEMUNG FINANCIAL CORP produced more free cash flow last quarter ($43.8M vs $-2.3M). Over the past eight quarters, RxSight, Inc.'s revenue compounded faster (5.1% CAGR vs 0.2%).
Chemung Canal Trust Company is a New York State chartered trust company based in Elmira, New York. It was founded as a publicly traded bank in 1833.
RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.
CHMG vs RXST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.8M | $32.6M |
| Net Profit | $7.7M | $-9.2M |
| Gross Margin | — | 77.5% |
| Operating Margin | 46.1% | -34.8% |
| Net Margin | 32.5% | -28.1% |
| Revenue YoY | 20.3% | -18.9% |
| Net Profit YoY | 30.9% | -54.1% |
| EPS (diluted) | $1.61 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.8M | $32.6M | ||
| Q3 25 | $28.8M | $30.3M | ||
| Q2 25 | $10.1M | $33.6M | ||
| Q1 25 | $25.7M | $37.9M | ||
| Q4 24 | $25.9M | $40.2M | ||
| Q3 24 | $24.3M | $35.3M | ||
| Q2 24 | $23.4M | $34.9M | ||
| Q1 24 | $23.7M | $29.5M |
| Q4 25 | $7.7M | $-9.2M | ||
| Q3 25 | $7.8M | $-9.8M | ||
| Q2 25 | $-6.5M | $-11.8M | ||
| Q1 25 | $6.0M | $-8.2M | ||
| Q4 24 | $5.9M | $-5.9M | ||
| Q3 24 | $5.7M | $-6.3M | ||
| Q2 24 | $5.0M | $-6.1M | ||
| Q1 24 | $7.0M | $-9.1M |
| Q4 25 | — | 77.5% | ||
| Q3 25 | — | 79.9% | ||
| Q2 25 | — | 74.9% | ||
| Q1 25 | — | 74.8% | ||
| Q4 24 | — | 71.6% | ||
| Q3 24 | — | 71.4% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | — | 70.1% |
| Q4 25 | 46.1% | -34.8% | ||
| Q3 25 | 35.0% | -40.1% | ||
| Q2 25 | -87.2% | -41.6% | ||
| Q1 25 | 29.9% | -28.2% | ||
| Q4 24 | 29.0% | -21.5% | ||
| Q3 24 | 29.8% | -26.1% | ||
| Q2 24 | 26.8% | -23.9% | ||
| Q1 24 | 38.3% | -36.2% |
| Q4 25 | 32.5% | -28.1% | ||
| Q3 25 | 27.1% | -32.4% | ||
| Q2 25 | -63.9% | -35.0% | ||
| Q1 25 | 23.4% | -21.6% | ||
| Q4 24 | 29.8% | -14.8% | ||
| Q3 24 | 23.5% | -17.9% | ||
| Q2 24 | 21.3% | -17.4% | ||
| Q1 24 | 29.7% | -30.8% |
| Q4 25 | $1.61 | $-0.22 | ||
| Q3 25 | $1.62 | $-0.24 | ||
| Q2 25 | $-1.35 | $-0.29 | ||
| Q1 25 | $1.26 | $-0.20 | ||
| Q4 24 | $1.24 | $-0.14 | ||
| Q3 24 | $1.19 | $-0.16 | ||
| Q2 24 | $1.05 | $-0.16 | ||
| Q1 24 | $1.48 | $-0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $50.1M | $228.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $254.7M | $275.7M |
| Total Assets | $2.7B | $311.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $50.1M | $228.1M | ||
| Q3 25 | $107.6M | $227.5M | ||
| Q2 25 | $320.1M | $227.5M | ||
| Q1 25 | $53.4M | $229.3M | ||
| Q4 24 | $47.0M | $237.2M | ||
| Q3 24 | $80.4M | $237.1M | ||
| Q2 24 | $70.2M | $233.3M | ||
| Q1 24 | $94.9M | $125.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $99.1M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $254.7M | $275.7M | ||
| Q3 25 | $245.3M | $276.0M | ||
| Q2 25 | $235.0M | $278.0M | ||
| Q1 25 | $228.3M | $279.3M | ||
| Q4 24 | $215.3M | $281.2M | ||
| Q3 24 | $220.7M | $277.3M | ||
| Q2 24 | $201.2M | $275.2M | ||
| Q1 24 | $197.1M | $163.9M |
| Q4 25 | $2.7B | $311.8M | ||
| Q3 25 | $2.7B | $308.5M | ||
| Q2 25 | $2.9B | $309.0M | ||
| Q1 25 | $2.8B | $313.0M | ||
| Q4 24 | $2.8B | $318.6M | ||
| Q3 24 | $2.8B | $310.5M | ||
| Q2 24 | $2.8B | $305.5M | ||
| Q1 24 | $2.8B | $183.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.42× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.5M | $-1.1M |
| Free Cash FlowOCF − Capex | $43.8M | $-2.3M |
| FCF MarginFCF / Revenue | 183.7% | -6.9% |
| Capex IntensityCapex / Revenue | 7.1% | 3.5% |
| Cash ConversionOCF / Net Profit | 5.88× | — |
| TTM Free Cash FlowTrailing 4 quarters | $71.9M | $-19.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.5M | $-1.1M | ||
| Q3 25 | $12.2M | $-1.2M | ||
| Q2 25 | $9.7M | $-4.4M | ||
| Q1 25 | $7.2M | $-8.8M | ||
| Q4 24 | $29.8M | $-4.3M | ||
| Q3 24 | $9.2M | $650.0K | ||
| Q2 24 | $6.5M | $-4.0M | ||
| Q1 24 | $7.9M | $-9.3M |
| Q4 25 | $43.8M | $-2.3M | ||
| Q3 25 | $11.8M | $-1.8M | ||
| Q2 25 | $9.4M | $-5.9M | ||
| Q1 25 | $6.9M | $-9.4M | ||
| Q4 24 | $26.2M | $-5.1M | ||
| Q3 24 | $8.6M | $-453.0K | ||
| Q2 24 | $5.5M | $-5.5M | ||
| Q1 24 | $7.9M | $-11.3M |
| Q4 25 | 183.7% | -6.9% | ||
| Q3 25 | 41.1% | -5.8% | ||
| Q2 25 | 92.9% | -17.6% | ||
| Q1 25 | 26.7% | -24.8% | ||
| Q4 24 | 101.2% | -12.7% | ||
| Q3 24 | 35.2% | -1.3% | ||
| Q2 24 | 23.4% | -15.9% | ||
| Q1 24 | 33.1% | -38.2% |
| Q4 25 | 7.1% | 3.5% | ||
| Q3 25 | 1.4% | 1.9% | ||
| Q2 25 | 3.6% | 4.6% | ||
| Q1 25 | 1.3% | 1.5% | ||
| Q4 24 | 14.0% | 2.1% | ||
| Q3 24 | 2.5% | 3.1% | ||
| Q2 24 | 4.4% | 4.4% | ||
| Q1 24 | 0.3% | 6.7% |
| Q4 25 | 5.88× | — | ||
| Q3 25 | 1.57× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.19× | — | ||
| Q4 24 | 5.04× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.30× | — | ||
| Q1 24 | 1.13× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CHMG
Segment breakdown not available.
RXST
| Rxlal | $28.2M | 86% |
| LDD | $3.0M | 9% |
| Service Warranty Service Contracts And Accessories | $1.5M | 4% |
